A detailed history of Spinnaker Trust transactions in Novartis Ag stock. As of the latest transaction made, Spinnaker Trust holds 1,759 shares of NVS stock, worth $175,847. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,759
Holding current value
$175,847
% of portfolio
0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$106.13 - $120.89 $186,682 - $212,645
1,759 New
1,759 $202,000
Q2 2023

Aug 01, 2023

BUY
$92.52 - $104.91 $190,498 - $216,009
2,059 New
2,059 $207,000
Q4 2022

Feb 02, 2023

SELL
$75.55 - $92.52 $16,318 - $19,984
-216 Reduced 4.58%
4,504 $408,000
Q2 2022

Jul 25, 2022

BUY
$80.52 - $93.75 $26,893 - $31,312
334 Added 7.62%
4,720 $399,000
Q1 2022

May 02, 2022

SELL
$80.11 - $90.62 $38,052 - $43,044
-475 Reduced 9.77%
4,386 $385,000
Q2 2021

Aug 09, 2021

SELL
$85.24 - $94.15 $17,048 - $18,830
-200 Reduced 3.95%
4,861 $443,000
Q1 2021

Apr 30, 2021

BUY
$83.5 - $98.47 $57,782 - $68,141
692 Added 15.84%
5,061 $432,000
Q2 2020

Jul 21, 2020

BUY
$80.93 - $91.1 $12,625 - $14,211
156 Added 3.7%
4,369 $381,000
Q1 2020

May 05, 2020

BUY
$70.67 - $99.01 $47,348 - $66,336
670 Added 18.91%
4,213 $347,000
Q4 2019

Feb 05, 2020

SELL
$84.35 - $95.37 $59,888 - $67,712
-710 Reduced 16.69%
3,543 $335,000
Q3 2019

Nov 12, 2019

BUY
$85.54 - $94.26 $44,053 - $48,543
515 Added 13.78%
4,253 $369,000
Q2 2019

Jul 11, 2019

SELL
$75.4 - $92.8 $15,532 - $19,116
-206 Reduced 5.22%
3,738 $340,000
Q3 2018

Oct 23, 2018

BUY
$66.94 - $77.43 $72,362 - $83,701
1,081 Added 37.76%
3,944 $339,000
Q2 2018

Aug 02, 2018

BUY
$64.91 - $73.36 $908 - $1,027
14 Added 0.49%
2,863 $215,000
Q1 2018

May 10, 2018

SELL
$70.39 - $84.15 $6,898 - $8,246
-98 Reduced 3.33%
2,849 $229,000
Q3 2017

Oct 26, 2017

BUY
$74.14 - $77.27 $218,490 - $227,714
2,947
2,947 $252,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $215B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Spinnaker Trust Portfolio

Follow Spinnaker Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spinnaker Trust, based on Form 13F filings with the SEC.

News

Stay updated on Spinnaker Trust with notifications on news.